Please enable JavaScript to continue using this application.

Compare $EQ vs $ICCC | Chartloom

Compare

$EQ vs $ICCC

Equillium Inc · ImmuCell Corp

Equillium Inc

ICCC

ImmuCell Corp

Compare $EQ vs $ICCC

Comparing Equillium Inc and ImmuCell Corp

EQEquillium Inc

ICCCImmuCell Corp

EQEquillium Inc

Market cap

$89M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.8%

52W performance

-4.1%

FCF yield

-22.5%

ICCCImmuCell Corp

Market cap

$89M

P/E (TTM)

114.37x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.5%

YTD performance

65.5%

52W performance

48.7%

FCF yield

4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ICCC

Detailed metrics comparison

Equillium Inc

ICCC

ImmuCell Corp

Market Cap

EQ$89M

ICCC$89M

Enterprise Value

EQ$32M

ICCC$88M

Price

EQ$1.41

ICCC$9.80

P/E Ratio

EQN/A

ICCC114.37x

P/S Ratio

EQ2.18x

ICCC2.89x

EV/Sales

EQ0.78x

ICCC2.87x

EV/EBITDA

EQ0.00x

ICCC14.10x

P/B Ratio

EQ1.60x

ICCC2.82x

P/FCF Ratio

EQN/A

ICCC21.04x

EV/FCF

EQ-1.59x

ICCC20.91x

PEG Ratio

EQN/A

ICCCN/A

Forward P/E (NTM)

EQN/A

ICCCN/A

Forward P/S (NTM)

EQN/A

ICCCN/A

Revenue (TTM)

EQ$0

ICCC$31M

Revenue Growth (YoY)

EQN/A

ICCC8.5%

Forward Rev Growth

EQ0.0%

ICCC0.0%

Gross Margin (TTM)

EQ0.0%

ICCC40.3%

Operating Margin (TTM)

EQ0.0%

ICCC3.9%

EBITDA Margin (TTM)

EQ0.0%

ICCC20.4%

Net Margin (TTM)

EQ0.0%

ICCC2.6%

FCF Margin (TTM)

EQN/A

ICCC13.7%

Net Income (TTM)

EQ$-18M

ICCC$787K

FCF (TTM)

EQ$-20M

ICCC$4M

EPS (TTM)

EQ-$0.15

ICCC$0.09

ROE (TTM)

EQ-6143.0%

ICCC2.7%

ROA (TTM)

EQ-5372.0%

ICCC1.8%

ROIC (TTM)

EQ-6143.0%

ICCC2.1%

Cash

EQ$57M

ICCC$9M

Debt

EQ$0

ICCC$8M

Net Cash/Debt

EQ$57M

ICCC$557K

Current Ratio (TTM)

EQ23.40x

ICCC4.75x

Quick Ratio (TTM)

EQ23.07x

ICCC2.65x

Debt/Equity (TTM)

EQ0.00x

ICCC0.26x

Debt/Assets (TTM)

EQ0.0%

ICCC0.0%

Interest Coverage (TTM)

EQN/A

ICCCN/A

Net Debt/EBITDA (TTM)

EQ0.00x

ICCC0.00x

Beta

EQ2.07

ICCC0.60

52W Performance

EQ-4.1%

ICCC48.7%

YTD Performance

EQ-7.8%

ICCC65.5%

% from 52W High

EQ-60.2%

ICCC-19.0%

% from 52W Low

EQ85.5%

ICCC116.8%

Asset Turnover (TTM)

EQ1.12x

ICCC0.69x

FCF Yield (TTM)

EQ-22.5%

ICCC4.8%

Earnings Yield (TTM)

EQ-20.2%

ICCC0.9%

Dividend Yield (TTM)

EQN/A

ICCCN/A

Rule of 40

EQ0.0

ICCC22.2

EV/GP/RG

EQN/A

ICCCN/A

Ticker research

View EQ research View ICCC research

Metric	EQ Equillium Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$89M	$89M
Enterprise Value	$32M	$88M
Price	$1.41	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	2.18x	2.89x
EV/Sales	0.78x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	1.60x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-1.59x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$31M
Revenue Growth (YoY)	N/A	8.5%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	0.0%	20.4%
Net Margin (TTM)	0.0%	2.6%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-18M	$787K
FCF (TTM)	$-20M	$4M
EPS (TTM)	-$0.15	$0.09
ROE (TTM)	-6143.0%	2.7%
ROA (TTM)	-5372.0%	1.8%
ROIC (TTM)	-6143.0%	2.1%
Financial Health
Cash	$57M	$9M
Debt	$0	$8M
Net Cash/Debt	$57M	$557K
Current Ratio (TTM)	23.40x	4.75x
Quick Ratio (TTM)	23.07x	2.65x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	0.60
52W Performance	-4.1%	48.7%
YTD Performance	-7.8%	65.5%
% from 52W High	-60.2%	-19.0%
% from 52W Low	85.5%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.69x
FCF Yield (TTM)	-22.5%	4.8%
Earnings Yield (TTM)	-20.2%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	22.2
EV/GP/RG	N/A	N/A
Ticker research	View EQ research	View ICCC research

Valuation

P/E Ratio

ICCC

114.37x

P/S Ratio

2.18x

ICCC

2.89x

EV/FCF

-1.59x

ICCC

20.91x

Growth & revenue

Revenue Growth TTM

ICCC

8.5%

Forward Revenue Growth

0.0%

ICCC

0.0%

Profitability & performance

Gross Margin

ICCC

40.3%

0.0%

ROE

ICCC

2.7%

-6143.0%

FCF Yield %

ICCC

4.8%

-22.5%

52-Week Performance

ICCC

48.7%

-4.1%

Detailed metrics comparison

Equillium Inc

ICCC

ImmuCell Corp

Market Cap

EQ$89M

ICCC$89M

Enterprise Value

EQ$32M

ICCC$88M

Price

EQ$1.41

ICCC$9.80

P/E Ratio

EQN/A

ICCC114.37x

P/S Ratio

EQ2.18x

ICCC2.89x

EV/Sales

EQ0.78x

ICCC2.87x

EV/EBITDA

EQ0.00x

ICCC14.10x

P/B Ratio

EQ1.60x

ICCC2.82x

P/FCF Ratio

EQN/A

ICCC21.04x

EV/FCF

EQ-1.59x

ICCC20.91x

PEG Ratio

EQN/A

ICCCN/A

Forward P/E (NTM)

EQN/A

ICCCN/A

Forward P/S (NTM)

EQN/A

ICCCN/A

Revenue (TTM)

EQ$0

ICCC$31M

Revenue Growth (YoY)

EQN/A

ICCC8.5%

Forward Rev Growth

EQ0.0%

ICCC0.0%

Gross Margin (TTM)

EQ0.0%

ICCC40.3%

Operating Margin (TTM)

EQ0.0%

ICCC3.9%

EBITDA Margin (TTM)

EQ0.0%

ICCC20.4%

Net Margin (TTM)

EQ0.0%

ICCC2.6%

FCF Margin (TTM)

EQN/A

ICCC13.7%

Net Income (TTM)

EQ$-18M

ICCC$787K

FCF (TTM)

EQ$-20M

ICCC$4M

EPS (TTM)

EQ-$0.15

ICCC$0.09

ROE (TTM)

EQ-6143.0%

ICCC2.7%

ROA (TTM)

EQ-5372.0%

ICCC1.8%

ROIC (TTM)

EQ-6143.0%

ICCC2.1%

Cash

EQ$57M

ICCC$9M

Debt

EQ$0

ICCC$8M

Net Cash/Debt

EQ$57M

ICCC$557K

Current Ratio (TTM)

EQ23.40x

ICCC4.75x

Quick Ratio (TTM)

EQ23.07x

ICCC2.65x

Debt/Equity (TTM)

EQ0.00x

ICCC0.26x

Debt/Assets (TTM)

EQ0.0%

ICCC0.0%

Interest Coverage (TTM)

EQN/A

ICCCN/A

Net Debt/EBITDA (TTM)

EQ0.00x

ICCC0.00x

Beta

EQ2.07

ICCC0.60

52W Performance

EQ-4.1%

ICCC48.7%

YTD Performance

EQ-7.8%

ICCC65.5%

% from 52W High

EQ-60.2%

ICCC-19.0%

% from 52W Low

EQ85.5%

ICCC116.8%

Asset Turnover (TTM)

EQ1.12x

ICCC0.69x

FCF Yield (TTM)

EQ-22.5%

ICCC4.8%

Earnings Yield (TTM)

EQ-20.2%

ICCC0.9%

Dividend Yield (TTM)

EQN/A

ICCCN/A

Rule of 40

EQ0.0

ICCC22.2

EV/GP/RG

EQN/A

ICCCN/A

Ticker research

View EQ research View ICCC research

Metric	EQ Equillium Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$89M	$89M
Enterprise Value	$32M	$88M
Price	$1.41	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	2.18x	2.89x
EV/Sales	0.78x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	1.60x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-1.59x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$31M
Revenue Growth (YoY)	N/A	8.5%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	0.0%	20.4%
Net Margin (TTM)	0.0%	2.6%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-18M	$787K
FCF (TTM)	$-20M	$4M
EPS (TTM)	-$0.15	$0.09
ROE (TTM)	-6143.0%	2.7%
ROA (TTM)	-5372.0%	1.8%
ROIC (TTM)	-6143.0%	2.1%
Financial Health
Cash	$57M	$9M
Debt	$0	$8M
Net Cash/Debt	$57M	$557K
Current Ratio (TTM)	23.40x	4.75x
Quick Ratio (TTM)	23.07x	2.65x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	0.60
52W Performance	-4.1%	48.7%
YTD Performance	-7.8%	65.5%
% from 52W High	-60.2%	-19.0%
% from 52W Low	85.5%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.69x
FCF Yield (TTM)	-22.5%	4.8%
Earnings Yield (TTM)	-20.2%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	22.2
EV/GP/RG	N/A	N/A
Ticker research	View EQ research	View ICCC research